Shum Financial Group Inc. Takes $1.02 Million Position in Procter & Gamble Company (The) $PG

Shum Financial Group Inc. bought a new position in Procter & Gamble Company (The) (NYSE:PG) in the 3rd quarter, HoldingsChannel.com reports. The firm bought 6,640 shares of the company’s stock, valued at approximately $1,020,000.

A number of other hedge funds also recently made changes to their positions in the business. MOKAN Wealth Management Inc. raised its stake in shares of Procter & Gamble by 13.7% in the second quarter. MOKAN Wealth Management Inc. now owns 15,319 shares of the company’s stock valued at $2,442,000 after acquiring an additional 1,846 shares during the last quarter. Czech National Bank increased its stake in shares of Procter & Gamble by 3.8% in the third quarter. Czech National Bank now owns 594,914 shares of the company’s stock valued at $91,409,000 after buying an additional 21,825 shares in the last quarter. Vega Investment Solutions lifted its position in Procter & Gamble by 1.3% during the 2nd quarter. Vega Investment Solutions now owns 638,400 shares of the company’s stock worth $101,710,000 after buying an additional 8,500 shares in the last quarter. Westerkirk Capital Inc. bought a new stake in Procter & Gamble during the 2nd quarter worth about $4,796,000. Finally, Caliber Wealth Management LLC KS raised its stake in shares of Procter & Gamble by 36.2% in the second quarter. Caliber Wealth Management LLC KS now owns 17,798 shares of the company’s stock worth $2,836,000 after acquiring an additional 4,730 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Activity at Procter & Gamble

In other news, COO Shailesh Jejurikar sold 3,986 shares of Procter & Gamble stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $606,788.78. Following the transaction, the chief operating officer owned 46,899 shares in the company, valued at $7,139,434.77. The trade was a 7.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Jennifer L. Davis sold 3,227 shares of the business’s stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $491,246.21. Following the completion of the sale, the chief executive officer directly owned 61,764 shares in the company, valued at approximately $9,402,333.72. This represents a 4.97% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 30,308 shares of company stock valued at $4,611,852 over the last 90 days. Insiders own 0.20% of the company’s stock.

Analyst Upgrades and Downgrades

PG has been the subject of a number of research reports. Dbs Bank raised shares of Procter & Gamble to a “hold” rating in a report on Friday, December 5th. Raymond James Financial decreased their price objective on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a research report on Monday, October 20th. Wells Fargo & Company dropped their target price on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research report on Thursday, September 25th. JPMorgan Chase & Co. cut their price target on Procter & Gamble from $165.00 to $157.00 and set a “neutral” rating on the stock in a research note on Thursday, December 18th. Finally, Morgan Stanley set a $175.00 price objective on Procter & Gamble in a research report on Monday, October 27th. Thirteen research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $171.38.

Procter & Gamble Stock Down 0.3%

Shares of NYSE:PG opened at $144.07 on Wednesday. The company has a 50 day moving average price of $146.51 and a two-hundred day moving average price of $152.47. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.51 and a current ratio of 0.71. The company has a market capitalization of $336.64 billion, a PE ratio of 21.03, a PEG ratio of 4.87 and a beta of 0.39. Procter & Gamble Company has a 52 week low of $138.14 and a 52 week high of $179.99.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, topping analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The company had revenue of $22.39 billion for the quarter, compared to analysts’ expectations of $22.23 billion. During the same period last year, the firm posted $1.93 earnings per share. The business’s quarterly revenue was up 3.0% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, November 17th. Shareholders of record on Friday, October 24th were issued a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 2.9%. The ex-dividend date was Friday, October 24th. Procter & Gamble’s dividend payout ratio is 61.75%.

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.